RxDoctor Payments Data

Kirstyn Vega, PA

Physician Assistant · Monroe, NCNPI 1184961435

Payments from drug & device makers

$2,123in general payments, 2019–2025

Across 110 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$509
  • Sanofi$412
  • Johnson & Johnson$342
  • AbbVie$221
  • UCB, Inc.$127
  • Incyte Corporation$111
  • plus $400 from 11 others

What the payments were for

  • Food & beverage$1,93091%
  • Education$1939%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,123 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$232,823
Medicare patients
716
Services billed
5,250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa16$337,899
Humira(Cf) PenAdalimumab15$224,875
Dupixent PenDupilumab44$163,230
Cosentyx Sensoready (2 Pens)Secukinumab16$139,629
OpzeluraRuxolitinib Phosphate14$30,208
Clobetasol Propionate200$8,465
Fluorouracil54$4,305
Ketoconazole250$4,058
Tacrolimus24$3,902
Tretinoin38$3,395
Triamcinolone Acetonide300$3,209
Doxycycline Hyclate246$2,748
Betamethasone Valerate92$2,576
Ivermectin12$2,165
MethotrexateMethotrexate Sodium59$1,044

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Incyte CorporationOpzelura$111$30,20814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Monroe

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →